Status:
COMPLETED
Highlighting the Benefits of a Screening Protocol Delivered by Orthoptists to Identify Visual Impairment in Children Aged 3 to 4
Lead Sponsor:
Clinique Rive Gauche
Conditions:
Visual Impairment in Children
Eligibility:
All Genders
3-4 years
Brief Summary
Visual developmental abnormalities affect 10 to 15% of the population under 6 years of age and leads to amblyopia in 30% of cases if left untreated. Untreated amblyopia in adulthood has consequences o...
Eligibility Criteria
Inclusion
- Children from 3 to 4 years old consulting for a screening of visual disorders,
- Patients registered with French social security scheme,
- Not participating in any other clinical study,
- Consent obtained from one of the two parents or the legal representative.
Exclusion
- Children whose parent or legal representative is vulnerable according to article L1121-6 of the CSP,
- Children whose parent or legal guardian is under guardianship or trusteeship or under legal protection,
- Children, whose parent or legal guardian is unable to give consent, or is protected by law.
Key Trial Info
Start Date :
October 4 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 28 2021
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04395560
Start Date
October 4 2020
End Date
June 28 2021
Last Update
July 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ophtalmologie Rive Gauche
Toulouse, Occitanie, France, 31300